#$%^&*AU2017204319A120170720.pdf#####The present invention provides for microvesicles (membrane coated bodies) isolated from mesenchymal stem cells for use in immunosuppressive therapy, such as for treating autoimmune diseases and graft-versus-host-disease. Pharmaceutical compositions comprising such microvesicles as an active principle are also provided.